Suggested Topics within your search.
Suggested Topics within your search.
- Cancer 1
- Immune System 1
- Immunity 1
- Orthopedic surgery 1
- Orthopedics 1
- Pediatrics 1
- Tumors 1
-
1341
Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer
Published 2025-01-01“…ATAC-, ChIP-, and RNA-seq analyses reveal that JUNB/AP1- and HDAC-mediated epigenetic programs repress pro-inflammatory signatures in tumor cells, antagonizing cJUN/AP1 signaling, favoring a therapy-responsive classical neoplastic state. …”
Get full text
Article -
1342
LAMB1 promotes proliferation and metastasis in nasopharyngeal carcinoma and shapes the immune-suppressive tumor microenvironment
Published 2025-03-01“…But at low level of fibroblasts, LAMB1 directly suppressed immune response. Tumors with high LAMB1 level had weak responses to immunotherapy. …”
Get full text
Article -
1343
TCfinder: Robust tumor cell discrimination in scRNA‐seq based on gene pathway activity
Published 2024-09-01Get full text
Article -
1344
Glomus tumor in a patient suffering from Von Recklinghausen disease. A case presentation.
Published 2005-04-01Subjects: “…tumor glómico…”
Get full text
Article -
1345
Pilomatrixoma of the parotid region: A benign tumor mimicking metastatic cutaneous squamous cell carcinoma
Published 2025-04-01“…Head and neck tumors in adults present a broad differential diagnosis, particularly when considering malignant neoplasms that require prompt diagnosis and intervention. …”
Get full text
Article -
1346
Effects of RARα ligand binding domain mutations on breast fibroepithelial tumor function and signaling
Published 2025-01-01“…Abstract Point mutations in the ligand binding domain of retinoic acid receptor alpha (RARα) are linked to breast fibroepithelial tumor development, but their role in solid tumorigenesis is unclear. …”
Get full text
Article -
1347
Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor Vaccines
Published 2015-01-01Get full text
Article -
1348
Editorial: Revealing the role of mitochondrial gene defects in tumor progression and developing mitochondrial-targeted drugs
Published 2025-02-01Subjects: Get full text
Article -
1349
MUNet: a novel framework for accurate brain tumor segmentation combining UNet and mamba networks
Published 2025-01-01Subjects: “…brain tumor segmentation…”
Get full text
Article -
1350
False Positive Radioiodinated Metaiodobenzylguanidine (123I-MIBG) Uptake in Undifferentiated Adrenal Malignant Tumor
Published 2015-01-01“…A final diagnosis of undifferentiated adrenal malignant tumor was rendered, instead of histologically malignant pheochromocytoma, despite the uptake of 123I-MIBG demonstrated by scintigraphy.…”
Get full text
Article -
1351
Knockout or inhibition of DHPS suppresses ovarian tumor growth and metastasis by attenuating the TGFβ pathway
Published 2025-01-01“…DHPS regulates the translation initiation factor EIF5A, and EIF5A2 knockout inhibits OC tumor growth and metastasis by blocking the epithelial-to-mesenchymal transition (EMT) and the TGFβ pathway. …”
Get full text
Article -
1352
Editorial: The impact of alkalizing the acidic tumor microenvironment to improve efficacy of cancer treatment, volume II
Published 2025-01-01Subjects: Get full text
Article -
1353
Stable periodic oscillations in a two-stage cancer model of tumor and immune system interactions
Published 2012-02-01Subjects: Get full text
Article -
1354
Molecule interacting with CasL-2 enhances tumor progression and alters radiosensitivity in cervical cancer
Published 2025-01-01“…Conclusion MICAL2 plays a critical role in tumor progression and radiotherapy resistance in cervical cancer. …”
Get full text
Article -
1355
Comparison of Epirubicin-Iodized Oil Suspension and Emulsion for Transcatheter Arterial Chemoembolization in VX2 Tumor
Published 2012-01-01“…Changes in plasma epirubicin concentration were compared over 24 h immediately after treatment, and enhanced ultrasonographic and histopathological analysis subsequently conducted 7 days after treatment to determine the growth ratio and proportion of viable tumor cells. The growth ratio and proportion of viable tumor cells were found to be significantly lower in the suspension group than in the emulsion group while the plasma epirubicin concentration was found to be significantly higher in the suspension group than in the emulsion group. …”
Get full text
Article -
1356
Tumores de las glándulas salivales mayores. Estudio de una serie de casos
Published 2012-09-01“…<strong>Fundamento:</strong> el estudio de las neoplasias de las glándulas salivales constituye uno de los problemas más complejos de la enfermedad tumoral de la cabeza y el cuello. <strong><br />Objetivo: </strong>determinar el comportamiento de los tumores de las glándulas salivales mayores. …”
Get full text
Article -
1357
ALKBH5 acts a tumor-suppressive biomarker and is associated with immunotherapy response in hepatocellular carcinoma
Published 2025-01-01Subjects: Get full text
Article -
1358
Glutathione-dependent system in the blood of gastric cancer patients with various tumor histotypes and prevalence of the disease
Published 2021-12-01Subjects: Get full text
Article -
1359
Biopsy location and tumor-associated macrophages in predicting malignant glioma recurrence using an in-silico model
Published 2025-01-01“…In conclusion, the results show that localized biopsies provided more information about tumor behavior, especially at the interface of tumor and normal tissue (Edge).…”
Get full text
Article -
1360
A Rare Case of Histiocytic Sarcoma Secondary to Gastrointestinal Stromal Tumor in the Stomach: Transdifferentiation or Synchronicity?
Published 2021-01-01“…Here, we report a 68-year-old female who developed histiocytic sarcoma following chemotherapy with imatinib (Gleevec) for gastrointestinal stromal tumor. Possible mechanisms of transdifferentiation from gastrointestinal stromal tumor to histiocytic sarcoma are discussed based on the features of our case and other two similar cases in the literature.…”
Get full text
Article